Navigation Links
BioSpecifics Technologies Corp. Announces Top-line Data from Phase 2 Trial of CCH for Canine Lipoma
Date:12/23/2013

LYNBROOK, N.Y., Dec. 23, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced top-line data from Chien-804, the placebo-controlled, double-blind, randomized Phase 2 trial evaluating the efficacy of collagenase clostridium histolyticum (CCH) in canines with benign subcutaneous lipomas. Lipomas are encapsulated deposits of fat often detected as bulges under the skin and affect an estimated 1.7 million dogs in the U.S. The trial did not meet its primary endpoint of a statistically significant post-treatment difference in the mean percent change in lipoma volume by CT scan; however, in the responder analysis there was a statistically significant reduction in lipoma surface area among dogs treated with CCH (p=0.0084).

"We are disappointed that the study did not meet its primary endpoint but are pleased that we achieved statistical significance in a responder analysis of those dogs who had a 50% decrease in lipoma surface area as measured by caliper, which is a standard method for measuring a subcutaneous lipoma," commented Thomas L. Wegman, President of BioSpecifics. "We are also encouraged to see a high satisfaction rating from the owners of pets who received CCH and hope to be able to offer them this minimally-invasive treatment."

Chien-804 enrolled 37 dogs in a single injection study randomized 1:1 CCH to placebo with lipoma volume being measured by CT scan and lipoma surface area being measured by caliper at baseline, one month and 90 days. The data at 90 days show a post-treatment difference in the mean percent change in lipoma volume by CT scan between the CCH and placebo-treated groups of -11.58% (p=0.52), whic
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
2. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
3. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
4. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
5. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
6. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013
9. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
10. UV Flu Technologies Expands Its International Footprint
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 AACC International unveiled the ... the grain scientists’ Centennial Meeting and also issued ... marks the 100th anniversary of AACC International (AACCI), ... Minnesota, U.S.A. on October 18-21, 2015. The meeting ... are looking to the next 100 years of ...
(Date:3/6/2015)... LYNBROOK, N.Y. , March 6, 2015 ... biopharmaceutical company developing first in class collagenase-based products marketed ... in the U.S. and XIAPEX ®  in the EU, ... and live audio webcast at 8:30 a.m. ET on ... and full year 2014 financial results and provide a ...
(Date:3/6/2015)... Anton Paar has released an application flash regarding ... Sodium hydroxide (NaOH, also known as lye or ... products including pretzels, colored fabrics, soap and aluminum foil. ... industry; its applications range from the food and beverage ... NaOH is used in the production of downstream ...
(Date:3/5/2015)... 2015  DuPont (NYSE: DD ) announced ... Conference held today in New York ... discussed strategy, progress and plans to accelerate growth ... and growing the company,s leading position in high-value advanced ... priority for DuPont. Discussing the company,s Advanced ...
Breaking Biology Technology:AACCI Unveils Scientific Symposia Sessions for Centennial Meeting 2BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2014 Financial Results on Friday, March 13, 2015 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4
... MYL ) today announced that it has received ... (FDA) for its Abbreviated New Drug Application (ANDA) for ... the generic version of Merck and Co.,s Singulair(R), which ... the 12 months ending March 31 for the same ...
... announced that it will present preliminary data from its Phase I ... the American Society of Clinical Oncologists (ASCO), in Orlando, Florida, USA.Dr ... be presenting the poster in the Develop m ... Vascula r ...
... May 28 The 500th patient was supported with ... as the,"Berlin Heart") since the first implantation of the ... device at the Children,s Memorial,Hospital in Chicago and has ... Alejandra had been diagnosed a few weeks ...
Cached Biology Technology:Oral VDA CYT997 - Phase I Clinical Trial Presentation at ASCO 2500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
(Date:2/5/2015)... FRANCISCO , January 28, 2015 ... Market Analysis, Size And Segment Forecasts To 2020 has ... global IR camera market is expected to reach USD ... by Grand View Research, Inc. IR cameras help identify ... and are expected to witness surging demand in medical ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... the University of Sheffield and Queen Mary, University of ... damage by sunlight when they are faced with extreme ... Nature, could have implications both for adapting plants to ... better harness solar energy. Photosynthesis in plants ...
... fickle as wind itself, can be groomed to become ... a lower cost than at present, according to scientists ... wind farms throughout a given geographic area with transmission ... into one powerful energy source. The findings are ...
... studied and controversial ecogeographical patterns, and refers to the ... Although it has been studied since the mid 19th ... techniques have made it possible to disentangle the underlying ... study in the journal Ecography, an international team of ...
Cached Biology News:Scientists unravel plants' natural defenses 2The power of multiples: Connecting wind farms can make a more reliable - and cheaper - power source 2The power of multiples: Connecting wind farms can make a more reliable - and cheaper - power source 3The power of multiples: Connecting wind farms can make a more reliable - and cheaper - power source 4
... (Vesicle-Associated Membrane Protein 2, Synaptobrevin ... share homology with any other ... is expected that the antibody ... Macaca multata and bovine due ...
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
Biology Products: